International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020)

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • University Hospitals of North Midlands NHS Trust
  • Goethe University Frankfurt a.M.
  • IRCCS Istituto Eugenio Medea - Bosisio Parini (LC)
  • University College London
  • University of Tübingen
  • Augsburg University
  • Ludwig Maximilian University of Munich
  • KU Leuven
  • Leibniz Institute for Neurobiology
  • Ghent University
  • University of Sheffield
  • Leiden University
  • Medical University of South Carolina
  • University of Potsdam
  • Migraine and Headache Clinic Königstein
  • Utah State University
  • University of Oslo
  • Otto von Guericke University Magdeburg
  • IRCCS Fondazione Istituto Neurologico Carlo Besta - Milano
  • National Institutes of Health (NIH)
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • University of Milan
  • Vienna University of Technology
  • SzeleSTIM GmbH
  • Universita Campus Bio-Medico di Roma
  • Complutense University
  • Queen Mary University of London
  • Babasaheb Bhimrao Ambedkar University
  • University of Würzburg
  • Harvard University
  • Maastricht University
  • University of Liege
  • China Academy of Chinese Medical Sciences
  • University of Leeds
  • Medical University of Vienna
  • University of California at Irvine
  • Universidade de Brasília
  • Mersin University
  • Vrije Universiteit Brussel
  • Odisee University College
  • The City College of New York
  • Erasmus University Rotterdam

Abstract

Given its non-invasive nature, there is increasing interest in the use of transcutaneous vagus nerve stimulation (tVNS) across basic, translational and clinical research. Contemporaneously, tVNS can be achieved by stimulating either the auricular branch or the cervical bundle of the vagus nerve, referred to as transcutaneous auricular vagus nerve stimulation(VNS) and transcutaneous cervical VNS, respectively. In order to advance the field in a systematic manner, studies using these technologies need to adequately report sufficient methodological detail to enable comparison of results between studies, replication of studies, as well as enhancing study participant safety. We systematically reviewed the existing tVNS literature to evaluate current reporting practices. Based on this review, and consensus among participating authors, we propose a set of minimal reporting items to guide future tVNS studies. The suggested items address specific technical aspects of the device and stimulation parameters. We also cover general recommendations including inclusion and exclusion criteria for participants, outcome parameters and the detailed reporting of side effects. Furthermore, we review strategies used to identify the optimal stimulation parameters for a given research setting and summarize ongoing developments in animal research with potential implications for the application of tVNS in humans. Finally, we discuss the potential of tVNS in future research as well as the associated challenges across several disciplines in research and clinical practice.

Details

Original languageEnglish
Article number568051
JournalFrontiers in human neuroscience
Volume14
Publication statusPublished - 23 Mar 2021
Peer-reviewedYes

External IDs

ORCID /0000-0002-2989-9561/work/160952402

Keywords

Sustainable Development Goals

Keywords

  • guidelines & recommendations, minimum reporting standards, transcutaneous auricular vagus nerve stimulation, transcutaneous cervical vagus nerve stimulation, transcutaneous vagus nerve stimulation